Researchers found that targeting the protein ZMYND8 can release IL-2 signaling to counteract T-cell exhaustion.

"Targeting ZMYND8 releases IL-2 signalling to override T-cell exhaustion" — Nature (current) · Science & Medicine

24 Sept 2026

What it means

This Nature paper reports that targeting the protein can restore signaling in exhausted T cells, reversing their dysfunction. is a state of reduced activity in chronic infections and cancer, and IL-2 is a cytokine that normally boosts T-cell proliferation and function. The study shows that ZMYND8 acts as a molecular brake on IL-2 signaling under chronic antigen stimulation; removing that brake re-energizes T cells, which could improve immunotherapies such as CAR-T cells and checkpoint inhibitors.

Accuracy & sourcesGrounded

The claim is based on a primary research article published in Nature, a top-tier peer-reviewed journal. The paper itself is the authoritative source, and the press releases from St. Jude Children's Research Hospital closely mirror the paper's findings. The solidity is high because it comes directly from the original research, though independent replication would further strengthen the conclusion.

Researchers found that targeting the protein ZMYND8 can release IL-2 signaling to counteract T-cell exhaustion.

What it means

Accuracy & sourcesGrounded

How new

Go deeper